Yizhen Guo, PharmD

Research Investigator
Bristol Myers Squibb, China (People's Republic)

Poster(s):

• (M-056) Time-to-event exposure-response based clinical utility index framework to facilitate optimal dose selection
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT